Patexia Research

Case number 2:20-cv-02597

Lawsuits

CELGENE CORPORATION v. BRECKENRIDGE PHARMACEUTICAL, INC. et al > Summary

Court Case Number 2:20-cv-02597

Filing Date Mar 10, 2020

Termination Date Apr 27, 2020

Court New Jersey District Court

Status Dismissed - Other

JudgesEsther Salas, Michael A. Hammer

Plaintiff

Defendant

2

Breckenridge Pharmaceutical

Natco Pharma Ltd.

Plaintiff Attorneys

9

Celgene
Attorney Name: William C. Baton
Saul Ewing LLP

Celgene
Attorney Name: Charles M. Lizza
Saul Ewing LLP

Celgene
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP

Celgene
Attorney Name: Dominic Cerrito
Quinn Emanuel Urquhart & Sullivan

Celgene
Attorney Name: Eric C. Stops
Quinn Emanuel Urquhart & Sullivan

Celgene
Attorney Name: Andrew S. Chalson
Quinn Emanuel Urquhart & Sullivan

Celgene
Attorney Name: Anthony M. Insogna
Jones Day

Celgene
Attorney Name: Cary Miller
Jones Day

Celgene
Attorney Name: Matthew J. Hertko
Jones Day

Defendant Attorneys

4

Breckenridge Pharmaceutical
Attorney Name: Robert Joseph Fettweis
Fleming.Ruvoldt

Breckenridge Pharmaceutical
Attorney Name: John W. Bateman
Parker Poe Adams & Bernstein LLP

Breckenridge Pharmaceutical
Attorney Name: Kyle Musgrove
Haynes and Boone, LLP

Breckenridge Pharmaceutical
Attorney Name: Elizabeth M. Crompton
Parker Poe Adams & Bernstein LLP

Cause

15:1126 Patent Infringement

Related Patents

Doc No	Title	Issue date
10555939	Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione	Feb 11, 2020